Fluticasone Propionate/Glycopyrronium Bromide/Salmeterol xinafoate

丙酸氟替卡松/格隆溴铵/昔萘酸沙美特罗

Report date: 2025/11/14 13:58:47

Base Information

Drug NameFluticasone Propionate/Glycopyrronium Bromide/Salmeterol xinafoate
Drug Alias NameFluticasone Propionate and Salmeterol xinafoate and Glycopyrronium Bromide丙酸氟替卡松+格隆溴铵+昔萘酸沙美特罗格隆溴铵/昔萘酸沙美特罗/丙酸氟替卡松Salmeterol xinafoate/Fluticasone Propionate/Glycopyrronium BromideGlycopyrronium Bromide/Salmeterol xinafoate/Fluticasone Propionate +[9] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor antagonistsCytosolic phospholipase A2 agonists +[4] 
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptorGlucocorticoid receptor +[4] 
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Fluticasone PropionateGlycopyrronium BromideSalmeterol xinafoate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCircassia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCircassia Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A